ValGenesis Inc. Announces the Appointment of Kevin O’Donnell as Chief Economical Officer
SAN FRANCISCO, Aug. 2, 2021 /PRNewswire/ — ValGenesis, Inc., the market chief in Company Validation Lifecycle Administration Systems (VLMS), today introduced the appointment of Kevin O’Donnell as Main Monetary Officer, effective August 2, 2021.
“We are delighted to welcome Kevin O’Donnell, a seasoned executive who adds finance and consulting abilities to our administration group. His impressive track record tends to make him a excellent suit for his new function at ValGenesis,” says Dr. Siva Samy, CEO & Chief Solution Strategist of ValGenesis, Inc. “We welcome him to our crew and look forward to his contributions in the financial and contractual management of ValGenesis’ fast world wide growth.”
“ValGenesis has a entire world class products with an great market place chance. The proficient administration workforce now has a disciplined emphasis on delivering outcomes. I search ahead to functioning with Siva and the administration crew to further increase the company’s approach, monetary and operational functionality,” suggests Kevin O’Donnell.
The CFO part nowadays requires to create a lot additional than correct, reliable historical economical reporting. Kevin is a option-oriented issue solver with practical experience in equally non-public and community corporations. His key power is providing enterprise and monetary counsel to operational administrators that will allow a firm to progress confidently in the direction of objectives. Kevin has experience with equally VC and PE-backed firms, with a wide assortment of merger, acquisition, and capital elevate transaction working experience. Prior to joining ValGenesis, Kevin was SVP of Finance and Accounting at SugarCRM, and Main Monetary Officer at Virtual Instruments, PanTerra Networks, and Cassatt Company.
ValGenesis is the 1st mover in paperless validation, and the inventor of the ValGenesis VLMS, the industry’s initially, proven, 100% paperless validation lifecycle management resolution, reliable by hundreds of lifestyle science clients as a technique of record for validation. Covering the overall lifecycle procedure, ValGenesis VLMS provides engineering options that are validated, entirely configurable and speedily deployable via a validated private secured Cloud. ValGenesis VLMS enables new degrees of collaboration, info integrity, danger administration and compliance with validation lifecycle management procedures.
About ValGenesis
ValGenesis, Inc. is the creator of an revolutionary computer software platform that serves as a foundation for controlling compliance-based validation actions in lifestyle science organizations. ValGenesis, Inc. is the provider of the to start with organization application that manages the company validation lifecycle approach. This resolution is completely compliant with U.S. Fda 21 CFR Component 11 and Annex 11 requirements. As the first absolutely paperless solution for electronic management of validation execution and acceptance, ValGenesis was selected by an marketplace peer evaluate committee to get the Parenteral Drug Association (PDA) New Revolutionary Technologies Award in 2005.
For a lot more info, pay a visit to www.valgenesis.com
Even more info:
Althea D’Sylva, ValGenesis Communications, +1 510-445-0505 Ex.1026 315585@e mail4pr.com
View initial written content to down load multimedia:https://www.prnewswire.com/information-releases/valgenesis-inc-announces-the-appointment-of-kevin-odonnell-as-chief-financial-officer-301345157.html
Source ValGenesis Inc.